arsenic trioxide has been researched along with Benign Cerebellar Neoplasms in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrade, AF; Delsin, LE; Klinger, PH; Queiroz, RG; Scrideli, CA; Tone, LG; Valera, ET | 1 |
| Beachy, PA; Gardner, D; Kim, J; Lee, JJ | 1 |
| Amano, S; Gao, Y; Gu, C; Koizumi, S; Namba, H; Tokuyama, T; Yokota, N | 1 |
| Beauchamp, EM; Uren, A | 1 |
| Hadden, MK; Wen, J | 1 |
3 review(s) available for arsenic trioxide and Benign Cerebellar Neoplasms
| Article | Year |
|---|---|
Inhibition of SHH pathway mechanisms by arsenic trioxide in pediatric medulloblastomas: a comprehensive literature review.
Topics: Adolescent; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Cerebellar Neoplasms; Child; Child, Preschool; Gene Expression Regulation, Neoplastic; Hedgehog Proteins; Humans; Infant; Medulloblastoma; Oxides; Signal Transduction | 2017 |
A new era for an ancient drug: arsenic trioxide and Hedgehog signaling.
Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Bone Neoplasms; Cerebellar Neoplasms; Hedgehog Proteins; Humans; Leukemia, Promyelocytic, Acute; Medulloblastoma; Oncogene Proteins; Oxides; Sarcoma, Ewing | 2012 |
Medulloblastoma drugs in development: Current leads, trials and drawbacks.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cerebellar Neoplasms; Humans; Medulloblastoma; Protein Kinase Inhibitors | 2021 |
2 other study(ies) available for arsenic trioxide and Benign Cerebellar Neoplasms
| Article | Year |
|---|---|
Arsenic antagonizes the Hedgehog pathway by preventing ciliary accumulation and reducing stability of the Gli2 transcriptional effector.
Topics: Animals; Arsenic Trioxide; Arsenicals; Arsenites; Cerebellar Neoplasms; Dose-Response Relationship, Drug; Hedgehog Proteins; Kruppel-Like Transcription Factors; Luciferases; Luminescent Proteins; Medulloblastoma; Mice; Mice, Knockout; Mice, Nude; Neoplasms, Experimental; NIH 3T3 Cells; Oxides; Protein Stability; Recombinant Fusion Proteins; Signal Transduction; Sodium Compounds; Transfection; Transplantation, Homologous; Tumor Suppressor Protein p53; Zinc Finger Protein Gli2 | 2010 |
Molecular targeting therapy against promyelocytic leukemia protein using arsenic acids in experimental intracranial medulloblastoma.
Topics: Animals; Antineoplastic Agents; Arsenates; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cerebellar Neoplasms; Cytarabine; Humans; Medulloblastoma; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Targeted Therapy; Neoplasms, Experimental; Nuclear Proteins; Oxides; Promyelocytic Leukemia Protein; Transcription Factors; Tumor Suppressor Proteins | 2012 |